Evidence map›Paper›PMID 40766568›Full record

ArticlebioRxiv : the preprint server for biology2025

Secretion and transfer of adipose lipoprotein lipase utilizes neutral sphingomyelinase 2 generated exosomes.

Terri A Pietka, Edward F Morris, Megan Basco, Jennifer Shew, Ni-Huiping Son, Zhenxiu Liu, Brandon A Davies, Ira J Goldberg, Clair Crewe, Nada A Abumrad

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Terri A PietkaDepartment of Medicine, Division of Nutritional Sciences and Obesity Research, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0003-0160-7261
Edward F MorrisDepartment of Medicine, Division of Nutritional Sciences and Obesity Research, Washington University School of Medicine, St Louis, MO, USA.
Megan BascoDepartment of Medicine, Division of Nutritional Sciences and Obesity Research, Washington University School of Medicine, St Louis, MO, USA.
Jennifer ShewDepartment of Medicine, Division of Nutritional Sciences and Obesity Research, Washington University School of Medicine, St Louis, MO, USA.
Ni-Huiping SonDepartment of Medicine, Holman Division of Endocrinology Diabetes and Metabolism, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0001-5941-3801
Zhenxiu LiuDepartment of Medicine, Holman Division of Endocrinology Diabetes and Metabolism, New York University Grossman School of Medicine, New York, NY, USA.
Brandon A DaviesDepartment of Biochemistry and Molecular Biology, Fraternal Order of Eagles Diabetes Research Center and Obesity Research and Education Initiative, University of Iowa, Iowa City, IA.ORCID 0000-0002-7168-8522
Ira J GoldbergDepartment of Medicine, Holman Division of Endocrinology Diabetes and Metabolism, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-8701-2201
Clair CreweDepartment of Cell Biology & Physiology, Washington University School of Medicine, St Louis, MO.ORCID 0000-0002-3117-5327
Nada A AbumradDepartment of Medicine, Division of Nutritional Sciences and Obesity Research, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0002-6475-0877

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Jonathan R Brestoff · 1999 to 2026
$30.2M
Pathways of Tissue Lipid UptakeR01HL045095 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ABUMRAD, NADA A., GOLDBERG, IRA J · 1991 to 2024
$6.9M
Regulation of Endothelial Lipase and HDL Metabolism by ANGPTL3R01HL162698 · NHLBI · UNIVERSITY OF IOWA · PI BRANDON Scott Joseph DAVIES · 2023 to 2026
$2.0M
Extracellular Vesiclemediated Regulation of MetabolismK99DK122019 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI CREWE, CLAIR · 2019 to 2020
$182k
NHLBI NIH HHS R01 HL045095NHLBI NIH HHS R01 HL162698NIDDK NIH HHS K99 DK122019NIDDK NIH HHS P30 DK056341
6 · The paper itself

Abstract

Lipoprotein lipase (LPL) is critical for clearance of circulating triglycerides and for tissue fatty acid supply. LPL is primarily synthesized and secreted by adipocytes into the interstitium and must traffic from there to the abluminal/basolateral side of capillary endothelial cells. There, LPL binds glycosylphosphatidylinositol-anchored protein 1, GPIHBP1, which stabilizes the protein and facilitates its movement across the endothelial cells to the luminal side where it functions in hydrolysis of lipoprotein triglycerides. Importance of LPL traffic is supported by findings that rare mutations in GPIHBP1 cause hypertriglyceridemia. However our understanding of how LPL is secreted by adipocytes and traffics to endothelial cells is incomplete. Here we examined the possibility that secretion and traffic of adipocyte LPL might involve generation of small extracellular vesicles (sEVs/exosomes) which often mediate cell-cell communication. Proteomic analysis of sEVs secreted by adipocytes showed them enriched in LPL. To study LPL secretion and transfer we generated human derived pre-adipocytes (HPA) that stably express tagged LPL (FLAG and His epitopes). LPL pulldown and sEV isolation from HPA conditioned media documented that greater than 70% of secreted LPL is present in sEVs. The mechanism for LPL secretion in sEVs was found to involve the ESCRT-independent neutral sphingomyelinase 2 (nSMase2) pathway, as treatment with the nSMase2 inhibitor GW4869 reduced secretion by 80%. The above observations were reproduced using highly sensitive nanoparticle flow cytometry. The sEV associated LPL has lipolytic activity and it is released by heparin addition indicating it is on the sEV surface. In addition, using human derived microvascular endothelial cells with stable lentiviral expression of GPIHBP1 we show that LPL positive sEVs transfer LPL to these cells, but not to control cells without GPIHBP1. Our findings suggest that sEV formation by nSMase2 controls adipocyte LPL secretion and traffic, that sEVs protect LPL activity and facilitate LPL transfer to GPIHBP1 on endothelial cells.

Identifiers

PMID40766568
PMCPMC12324428

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.